GlycoMimetics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlycoMimetics and other ETFs, options, and stocks.

About GLYC

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. 

CEO
Harout Semerjian
CEOHarout Semerjian
Employees
52
Employees52
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2003
Founded2003
Employees
52
Employees52

GLYC Key Statistics

Market cap
105.90M
Market cap105.90M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.14M
Average volume1.14M
High today
$2.05
High today$2.05
Low today
$2.03
Low today$2.03
Open price
$2.05
Open price$2.05
Volume
20.56K
Volume20.56K
52 Week high
$2.43
52 Week high$2.43
52 Week low
$0.51
52 Week low$0.51

GLYC Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 2, Pre-Market
ActualExpected Mar 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.